Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Revenue

In the year 2025, Tianjin TEDA Biomedical Engineering Company had annual revenue of 522.97M CNY with 35.67% growth. Tianjin TEDA Biomedical Engineering Company had revenue of 296.56M in the half year ending December 31, 2025.

• Revenue: 522.97M CNY
• Revenue Growth: +35.67%
• P/S Ratio: 0.55
• Revenue / Employee: 1.92M CNY
• Employees: 273
• Market Cap: 322.22M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	522.97M	137.48M	35.67%
Dec 31, 2024	385.48M	-12.52M	-3.14%
Dec 31, 2023	398.00M	-5.73M	-1.42%
Dec 31, 2022	403.73M	-72.66M	-15.25%
Dec 31, 2021	476.38M	107.03M	28.98%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 28, 2026

Data Sources Report a data error